Abstract:Background: Pathophysiologic changes of posttransplant lung ischemia/reperfusion injury are mediated by redundant cellular and humoral mechanisms. We investigated the protective effect of combined administration of platelet activating factor (PAF) and endothelin (ET) antagonists after prolonged ischemia in a small animal lung transplantation model.Methods: Orthotopic left Lung transplantation was performed after 20 hours cold ischemia in male Fischer (F344) rats weighing 200-250 g. Group I served as control. Ih Group II, donors received 1 mg/kg body weight of the endothelin antagonist TAK-044, and recipients 2 mg/kg. Group III was treated with the PAF antagonist TCV-309 (donor: 50 mu g/kg; recipient: 100 mu g/kg) (Takeda Chemicals Ltd.). Group IV received a combined treatment with both substances at the same dosage. Twenty-four hours after reperfusion, the native contralateral lung was occluded to assess gas exchange of the graft only, and 5 minutes later the thoracic aorta was punctured for arterial blood gas analysis (n = 5). In other animals (n = 5), lung tissue was frozen 24 hours after reperfusion and assessed for myeloperoxidase activity (MPO) and thiobarbituric acid reactive substances.Results: Combined inhibition of PAF and ET-1 at the receptor level resulted in significantly improved graft function as compared to controls (Group I), and to groups treated with either TAK-044 or TCV-309. This was determined by a higher arterial oxygen content (112 +/- 9 mmHg, p = .00061 vs control, 48 +/- 5 mmHg), reduced MPO activity (0.35 +/- 0.02 Delta hOD/mg/min,p = .000002 vs control, 1.1 +/- 0.1 Delta OD/mg/min) and reduced lipid peroxidation (59.5 +/- 2.5 pmol/g, p = .011 vs control, 78.5 +/- 4.1 pmol/g). The improvement of arterial oxygen (Group II 77 +/- 10 mmHg, p = .027 vs control; Group III 84 +/- 8 mmHg, p = .0081 vs control) and reduction of MPO activity (Group II 0.85 +/- 0.061 Delta OD/mg/min,p = .017; Group III 0.92 +/- 0.079 Delta OD/mg/min, p = .058) in groups treated with either a PAF antagonist or an ET antagonist was significantly less than in Group IV.Conclusions: Combined donor and recipient treatment with an ET antagonist and a PAF antagonist results in superior posttransplant graft function 24 hours after reperfusion, suggesting a synergistic role of ET-1 and PAF in the mediation of reperfusion injury in this model. Single treatment with either of the antagonists revealed only a slight improvement compared to untreated controls.

Preharvest Nitroprusside Flush Improves Posttransplantation Lung Function.

Nitroprusside Ameliorates Lung Allograft Reperfusion Injury.

Attenuation of lung graft reperfusion injury by a nitric oxide donor

New strategies to reduce ischemia/reperfusion injury following lung allotransplantation by substitution of the NO/cGMP pathway

Survival and Graft Function in A Large Animal Lung Transplant Model after 30 H Preservation and Substitution of the Nitric Oxide Pathway

Neutrophil modulation results in improved pulmonary function after 12 and 24 hours of preservation

The Nitric Oxide Synthase Cofactor Tetrahydrobiopterin Reduces Allograft Ischemia-Reperfusion Injury after Lung Transplantation.

Preventive effect of inhaled nitric oxide and pentoxifylline on ischemia/reperfusion injury after lung transplantation

Nitrite Reduces Acute Lung Injury and Improves Survival in a Rat Lung Transplantation Model

N-acetylcysteine attenuates lung ischemia-reperfusion injury after lung transplantation.

Reduction of lung allograft ischemia/reperfusion injury by tetrahydrobiopterin coenzyme of NOS.

Inhalative pre-treatment of donor lungs using the aerosolized prostacyclin analog iloprost ameliorates reperfusion injury

Impact of PAF antagonist BN 52021 (Ginkolide B) on post-ischemic graft function in clinical lung transplantation

Ex vivo treatment with inhaled N-acetylcysteine in porcine lung transplantation

REDUCTION OF LUNG ALLOGRAFT REPERFUSION INJURY BY TETRAHYDROBIOPTERIN (BH4), CO-ENZYME OF Cnos

Combined Treatment with Endothelin- and PAF-antagonists Reduces Posttransplant Lung Ischemia/reperfusion Injury.

Ex Vivo Lung Perfusion with β-Nicotinamide Adenine Dinucleotide (NAD+) Improves Ischemic Lung Function

EFFECTS OF NITRIC OXIDE ON REPERFUSION INJURY FOLLOWING PANCREATICODUODENAL TRANSPLANTATION IN RATS

8-Br-cyclic GMP given during reperfusion improves post-transplant lung edema and free radical injury

Perfusate adsorption during ex vivo lung perfusion improves early post-transplant lung function

Effect of aprotinin on improving graft function and inhibiting apoptosis of pulmonary cells of lung inplant after lung transplantation